$10 Billion to 190 Billion Bioeconomy: India’s Science Story touches New Heights in 12 Years says Dr Jitendra Singh

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic - ~20-fold bioeconomy expansion in 12 yrs — diversifies non-fossil GVA; targets biomanufacturing import substitution [S1][S4]. - Space economy currently ~2–3% of global; goal of 5-fold rise implies capturing ~8–10% share [S3].

Scientific / Technological - Convergence of AI + biology via Bio-AI Hubs (BioE3) [S4]. - Chandrayaan-3 + Covid vaccine (Covaxin, Covishield) cited as proof of indigenous capability [S1].

Administrative / Governance - IN-SPACe demonstrates single-window model for private participation [S3]. - Centre-State partnership: DBT–Assam MoU under BioE3 (Feb 2025) marks federal roll-out [S5 implicit in S4 listing].

Environmental - BioE3's "Environment" pillar targets carbon-neutral biomanufacturing, bio-based plastics, green chemistry [S4].

Geopolitical / Strategic - Positions India as biomanufacturing hub amid global supply chain diversification (post-Covid); space privatisation aligns with QUAD/Artemis cooperation [S1].

6. Recent Developments (12–18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources